Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis

被引:20
|
作者
Chamilos, Georgios [1 ]
Kontoyiannis, Dimitrios P. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Unit 402,1515 Holcombe Blvd, Houston, TX 77030 USA
关键词
Fungal infection; Paecilomyces; Resistance; Voriconazole;
D O I
10.1016/j.jinf.2005.02.005
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Paecilomyces variotii, an emerging hyalohyphomycetes, has been reported to be susceptible in vitro to voriconazole. We describe a case of disseminated P. variotii infection in a neutropenic child with relapsed leukaemia who was on voriconazole prophylaxis. The P. variotii isolate was resistant to voriconazole in vitro. The patient responded to liposomal amphotericin B. (C) 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:E225 / E228
页数:4
相关论文
共 50 条
  • [31] Paecilomyces variotii central nervous system infection in a patient with cancer
    Kantarcioglu, AS
    Hatemi, G
    Yücel, A
    De Hoog, GS
    Mandel, NM
    MYCOSES, 2003, 46 (1-2) : 45 - 50
  • [32] Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy
    Muñoz, P
    Marín, M
    Tornero, P
    Rabadán, PM
    Rodríguez-Creixéms, M
    Bouza, E
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) : 1499 - 1501
  • [33] Successful treatment with voriconazole of prolonged Paecilomyces lilacinus fungemia in a chronic hemodialyzed patient
    Labriola, L.
    Vandercam, B.
    Swinne, D.
    Jadoul, M.
    CLINICAL NEPHROLOGY, 2009, 71 (03) : 355 - 358
  • [34] Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia
    Al-Badriyeh, Daoud
    Slavin, Monica
    Liew, Danny
    Thursky, Karin
    Downey, Maria
    Grigg, Andrew
    Bajel, Ashish
    Stewart, Kay
    Kong, David C. M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (05) : 1052 - 1061
  • [35] A multidrug resistant oral Candida glabrata infection in an AIDS patient effectively treated with voriconazole
    Colebunders, R
    Florence, E
    Vreelust, I
    Swinne, D
    Noe, A
    AIDS, 2000, 14 : S131 - S132
  • [36] Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis
    Agrawal, Vaibhav
    Brinda, Bryan J.
    Farag, Sherif S.
    CASE REPORTS IN HEMATOLOGY, 2020, 2020
  • [37] Isolation and in vitro susceptibility to amphotericin B, itraconazole and posaconazole of voriconazole-resistant laboratory isolates of Aspergillus fumigatus
    Manavathu, EK
    Abraham, OC
    Chandrasekar, PH
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (03) : 130 - 137
  • [38] Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine
    Howden, BP
    Slavin, MA
    Schwarer, AP
    Mijch, AM
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2003, 22 (02) : 111 - 113
  • [39] Microsatellite Typing and Resistance Mechanism Analysis of Voriconazole-Resistant Aspergillus flavus Isolates in South Korean Hospitals
    Choi, Min Ji
    Won, Eun Jeong
    Joo, Min Young
    Park, Yeon-Joon
    Kim, Soo Hyun
    Shin, Myung Geun
    Shin, Jong Hee
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (02)
  • [40] Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia
    Shouldice, E
    Fernandez, C
    McCully, B
    Schmidt, M
    Fraser, R
    Cook, C
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (09) : 732 - 734